Skip to search formSkip to main contentSkip to account menu

MP-Myeloma Regimen

Known as: Melphalan-Prednisone Regimen 
A regimen consisting of melphalan and prednisone used as induction treatment for multiple myeloma.
National Institutes of Health

Related topics

Related topics

4 relations
MelphalanMultiple MyelomaPrednisonemelphalan/prednisone protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies RUNNING HEAD : Chr 1 abnormalities in MM treated with new drugs
Multiple Myeloma is a plasma cell disorder, characterized by malignant plasma cell infiltration in the bone marrow, serum and/or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)